Khatri, S.; Suchday, P.; Guddeti, A.; Nanna, S.; Gupta, S.; Darapaneni, H.; Mohammed, A.S.; Desai, R.; Imtiaz, H.
Endocan as a Novel Biomarker for Endothelial Dysfunction and Cardiovascular Prognosis in ST-Elevation Myocardial Infarction: A Contemporary Literature Review. J. Pers. Med. 2026, 16, 7.
https://doi.org/10.3390/jpm16010007
AMA Style
Khatri S, Suchday P, Guddeti A, Nanna S, Gupta S, Darapaneni H, Mohammed AS, Desai R, Imtiaz H.
Endocan as a Novel Biomarker for Endothelial Dysfunction and Cardiovascular Prognosis in ST-Elevation Myocardial Infarction: A Contemporary Literature Review. Journal of Personalized Medicine. 2026; 16(1):7.
https://doi.org/10.3390/jpm16010007
Chicago/Turabian Style
Khatri, Sourabh, Pooja Suchday, Ananth Guddeti, Supritha Nanna, Shashank Gupta, Haritha Darapaneni, Adil Sarvar Mohammed, Rupak Desai, and Hassaan Imtiaz.
2026. "Endocan as a Novel Biomarker for Endothelial Dysfunction and Cardiovascular Prognosis in ST-Elevation Myocardial Infarction: A Contemporary Literature Review" Journal of Personalized Medicine 16, no. 1: 7.
https://doi.org/10.3390/jpm16010007
APA Style
Khatri, S., Suchday, P., Guddeti, A., Nanna, S., Gupta, S., Darapaneni, H., Mohammed, A. S., Desai, R., & Imtiaz, H.
(2026). Endocan as a Novel Biomarker for Endothelial Dysfunction and Cardiovascular Prognosis in ST-Elevation Myocardial Infarction: A Contemporary Literature Review. Journal of Personalized Medicine, 16(1), 7.
https://doi.org/10.3390/jpm16010007